Literature DB >> 22323420

Hepatocellular carcinoma and model for end-stage liver disease exceptions: the more we understand, the more challenging the allocation gets.

Patrick G Northup, Carl L Berg.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22323420     DOI： 10.1002/lt.23409

Source DB:  PubMed          Journal:  Liver Transpl        ISSN： 1527-6465            Impact factor:   5.799


× No keyword cloud information.
  4 in total

1.  HCC patients suffer less from geographic differences in organ availability.

Authors:  C Schuetz; N Dong; E Smoot; N Elias; D A Schoenfeld; J F Markmann; H Yeh
Journal:  Am J Transplant       Date:  2013-09-06       Impact factor: 8.086

Review 2.  Surveillance for early diagnosis of hepatocellular carcinoma: how best to do it?

Authors:  Edoardo G Giannini; Alessandro Cucchetti; Virginia Erroi; Francesca Garuti; Federica Odaldi; Franco Trevisani
Journal:  World J Gastroenterol       Date:  2013-12-21       Impact factor: 5.742

Review 3.  Management of Hepatocellular Carcinoma: Current Status and Future Directions.

Authors:  Jennifer S Au; Catherine T Frenette
Journal:  Gut Liver       Date:  2015-07       Impact factor: 4.519

4.  Multimodality locoregional treatment strategies for bridging HCC patients before liver transplantation.

Authors:  Georg P Györi; D Moritz Felsenreich; Gerd R Silberhumer; Thomas Soliman; Gabriela A Berlakovich
Journal:  Eur Surg       Date:  2017-09-04       Impact factor: 0.953
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.